Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective

BACKGROUND: In phenylketonuria (PKU), modified casein glycomacropeptide supplements (CGMP-AA) are used as an alternative to the traditional phenylalanine (Phe)-free L-amino acid supplements (L-AA). However, studies focusing on the long-term nutritional status of CGMP-AA are lacking. This retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Pena, Maria João, Pinto, Alex, de Almeida, Manuela Ferreira, de Sousa Barbosa, Catarina, Ramos, Paula Cristina, Rocha, Sara, Guimas, Arlindo, Ribeiro, Rosa, Martins, Esmeralda, Bandeira, Anabela, Dias, Cláudia Camila, MacDonald, Anita, Borges, Nuno, Rocha, Júlio César
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881530/
https://www.ncbi.nlm.nih.gov/pubmed/33581730
http://dx.doi.org/10.1186/s13023-021-01721-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881530/
https://www.ncbi.nlm.nih.gov/pubmed/33581730
http://dx.doi.org/10.1186/s13023-021-01721-8

Ejemplares similares